ArticleDrug design, development and therapy2026

Methodological Considerations in the Bioequivalence Assessment of Recombinant Human Serum Albumin [Letter].

Peng Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.